Life Sciences

Marlborough medical device firm Hologic has made a play bolster its breast-conserving surgery portfolio with a $125-million acquisition.

New Jersey medical behemoth Johnson & Johnson could be eyeing Marlborough medical device giant Boston Scientific, according to a recent analyst report.

Marlborough medical device maker Hologic is expecting revenues from subsidiary Cynosure to be about $15 million less after it halted sales of a device due to a government warning.

More than one-third of all venture capital money invested in biopharmaceutical companies last year went to Massachusetts companies, with the bulk of those dollars headed to companies in Cambridge and nearby, according to a new industry report.

The chief financial officer of Holliston-based Harvard Bioscience has resigned shortly after the company reported record second quarter revenue.

A subsidiary of Marlborough medical device firm Hologic has landed the U.S. and Canadian distribution rights of a Pennsylvania medical equipment manufacturer's nitrous oxide and oxygen systems.

Despite just $5.8 million in cash to its name, Holliston organ bioengineering firm Biostage is eyeing a 2019 U.S. Food and Drug Administration application for its esophagus-regenerating device.

Marlborough medical device company Hologic is suspending the marketing and distribution of a vaginal heating device after the company receiving a warning from the U.S. Food and Drug Administration.

Holliston biotech Biostage is seeking to withdraw a registration statement with the SEC filed nearly one year ago after no securities had been issued or sold under the statement.

Mustang Bio's Worcester facility will play a role in a new exclusive partnership with a leading children's medical center to help develop treatments for an immunodeficiency disorder.